Coates v. Cluney

District Court, D. Hawaii·Decided August 29, 2023·No. 1:23-cv-00122·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF HAWAII

SCOTT COATES, Civ. No. 23-00122 JMS-WRP

Plaintiff, ORDER DISMISSING FIRST AMENDED PRISONER CIVIL v. RIGHTS COMPLAINT, ECF NO. 13, WITH PARTIAL LEAVE GRANTED SHANNON CLUNEY, et al., TO AMEND

Defendants.

ORDER DISMISSING FIRST AMENDED PRISONER CIVIL RIGHTS COMPLAINT, ECF NO. 13, WITH PARTIAL LEAVE GRANTED TO AMEND

Before the court is pro se Plaintiff Scott Coates’ (“Coates”) First Amended Prisoner Civil Rights Complaint (“FAC”) brought pursuant to 42 U.S.C. § 1983. ECF No. 13. In the FAC, Coates alleges that he was denied adequate medical care while he was incarcerated at the Halawa Correctional Facility (“HCF”), a state prison.1 After conducting the required screening pursuant to 28 U.S.C. § 1915(e)(2), the court DISMISSES the FAC with partial leave granted to amend. If Coates wants this action to proceed, he must file an amended pleading that cures the noted deficiencies in his claims on or before September 29,

1 Coates names Defendants Maura Tresch, Mandy Feldt, Romey Glidewell, Moani Cummings, and Caroline Mee in their individual and official capacities. See ECF No. 13 at PageID.69–PageID.71. 2023. In the alternative, Coates may inform the court in writing on or before September 29, 2023, that he would like to dismiss voluntarily this action pursuant

to Federal Rule of Civil Procedure 41(a)(1). I. STATUTORY SCREENING The court must screen any case in which a prisoner seeks redress from

a governmental entity or officer or employee of a governmental entity, or in which a plaintiff proceeds in forma pauperis. 28 U.S.C. §§ 1915(e)(2), 1915A(a); Jones v. Bock, 549 U.S. 199, 202 (2007) (“Among other reforms, the [Prison Litigation Reform Act of 1995] mandates early judicial screening of prisoner complaints.”).

During this screening, the court must dismiss any complaint, or any portion thereof, that is frivolous, malicious, fails to state a claim on which relief may be granted, or seeks damages from defendants who are immune from suit. See 28

U.S.C. §§ 1915(e)(2)(B) and 1915A(b); Harris v. Mangum, 863 F.3d 1133, 1137 (9th Cir. 2017); see also Harris v. Harris, 935 F.3d 670, 675 (9th Cir. 2019) (describing screening under 28 U.S.C. §§ 1915(e)(2)(B) and 1915A(a)–(b)). Screening under 28 U.S.C. §§ 1915(e)(2) and 1915A(a) involves the

same standard of review as that used under Federal Rule of Civil Procedure 12(b)(6). See Rosati v. Igbinoso, 791 F.3d 1037, 1039 (9th Cir. 2015) (per curiam). Under this standard, a complaint must “contain sufficient factual matter,

accepted as true, to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (internal quotation marks and citation omitted). A claim is “plausible” when the facts alleged support a reasonable inference that the

plaintiff is entitled to relief from a specific defendant for specific misconduct. See id. In conducting this screening, the court liberally construes pro se

litigants’ pleadings and resolves all doubts in their favor. See Hebbe v. Pliler, 627 F.3d 338, 342 (9th Cir. 2010) (citations omitted). The court must grant leave to amend if it appears the plaintiff can correct the defects in the complaint. See Lopez v. Smith, 203 F.3d 122, 1130 (9th Cir. 2000). When a claim cannot be saved by

amendment, however, dismissal with prejudice is appropriate. See Sylvia Landfield Tr. v. City of Los Angeles, 729 F.3d 1189, 1196 (9th Cir. 2013). II. BACKGROUND2

Sometime in 2021, Dr. Tresch, a primary care physician at the HCF, concluded that there was an “issue” with Coates’ right eye.3 ECF No. 13 at PageID.75. Dr. Tresch referred Coates to an ophthalmologist at Straub Medical

2 Coates’ factual allegations are accepted as true for purposes of screening. See Nordstrom v. Ryan, 762 F.3d 903, 908 (9th Cir. 2014).

3 In the original Complaint, Coates stated that he had pterygium on his right eye. ECF No. 1 at PageID.5. Pterygium is “a raised, fleshy, triangular-shaped growth” on the eye. Cleveland Clinic, Pterygium (Surfer’s Eye), https://my.clevelandclinic.org/health/diseases/ 22497-pterygium-surfers-eye (last visited Aug. 29, 2023). The condition’s main cause is long- term exposure to UV light. Id. An affected eye “may be red, swollen and irritated in mild cases. If pterygium grows, . . . vision may be blocked or blurred. Treatments include symptom- relieving eye drops and ointment to surgery if . . . vision is affected.” Id. Center who examined Coates in March 2022. Id. Two other ophthalmologists— one at EyeSight Hawaii and another at the Oculoplastics Center—examined Coates

in May 2022 and December 2022, respectively. Id. All three ophthalmologists diagnosed Coates with ocular cicatricial pemphigoid (“OCP”), a rare autoimmune disease.4 Id. at PageID.75–PageID.76. According to Coates, he should have been

seen by a rheumatologist, but treatment was “withheld” for fourteen months. Id. at PageID.75. In January 2023, Coates had an appointment at EyeSight Hawaii for “tear duct plugs.” Id. at PageID.76. Cummings, a registered nurse, cancelled this

appointment. Id. Cummings also cancelled a second appointment for Coates with the ophthalmologist at the Oculoplastics Center. Id. At some point, Glidewell, a nurse practitioner, ordered an injection of

methotrexate for Coates, but he refused it.5 Id. Glidewell later told Coates that she would inform the Hawaii Paroling Authority that Coates was refusing treatment.

4 OCP is “a form of mucous membrane pemphigoid (a group of rare, chronic autoimmune disorders) that affects the eyes.” See Autoimmune Association, What is Ocular cicatricial pemphigoid, https://autoimmune.org/disease-information/ocular-cicatricial- pemphigoid/ (last visited Aug. 29, 2023). “In the early stages, people with OCP generally experience chronic or relapsing conjunctivitis that is often characterized by tearing, irritation, burning, and/or mucus drainage. If left untreated, OCP can progress to severe conjunctiva scarring and vision loss.” Id.

5 Methotrexate is used to treat a variety of conditions, including autoimmune diseases. See WebMD, https://www.webmd.com/drugs/2/drug-3441/methotrexate-anti-rheumatic- oral/details (last visited Aug. 29, 2023). Id. Glidewell told Coates that this could affect his chances of being granted parole. Id.

Coates commenced this suit by signing the original Complaint on February 27, 2023. ECF No. 1 at PageID.8.

Free access — add to your briefcase to read the full text and ask questions with AI

Coates v. Cluney, (D. Haw. 2023).

Coates v. Cluney (Coates v. Cluney) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Rizzo v. Goode
423 U.S. 362 (Supreme Court, 1976)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
Pennhurst State School and Hospital v. Halderman
465 U.S. 89 (Supreme Court, 1984)
West v. Atkins
487 U.S. 42 (Supreme Court, 1988)
Will v. Michigan Department of State Police
491 U.S. 58 (Supreme Court, 1989)
Hafer v. Melo
502 U.S. 21 (Supreme Court, 1991)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Hebbe v. Pliler
627 F.3d 338 (Ninth Circuit, 2010)
Wolfson v. Brammer
616 F.3d 1045 (Ninth Circuit, 2010)
Johnson v. Duffy
588 F.2d 740 (Ninth Circuit, 1978)
May v. Enomoto
633 F.2d 164 (Ninth Circuit, 1980)
Toguchi v. Soon Hwang Chung
391 F.3d 1051 (Ninth Circuit, 2004)
Michael Lacey v. Joseph Arpaio
693 F.3d 896 (Ninth Circuit, 2012)
Sylvia Landfield Trust v. City of Los Angeles
729 F.3d 1189 (Ninth Circuit, 2013)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Cion Peralta v. T. Dillard
744 F.3d 1076 (Ninth Circuit, 2014)
Scott Nordstrom v. Charles Ryan
762 F.3d 903 (Ninth Circuit, 2014)
Philip Rosati v. Dr. Igbinoso
791 F.3d 1037 (Ninth Circuit, 2015)